Pancreas neuroendocrine tumors - not so rare or benign
نویسندگان
چکیده
منابع مشابه
Sinonasal Teratocarcinosarcoma- A Rare Tumour not so Rarely Misdiagnosed
Sinonasal teratocarcinosarcoma (STCS) is a rare, morphologically heterogeneous and highly aggressive tumour of ambiguous origin. It is characterized by the presence of benign and malignant epithelial, mesenchymal and neuroectodermal components. Because of their rarity and heterogeneity, these lesions are often misdiagnosed, leading to management difficulties. Adequate sampling with a high index...
متن کاملPharmacogenetics in neuroendocrine tumors of the pancreas.
Neuroendocrine tumors (NETs) arise from cells distributed throughout the endocrine system. Although, NETs are heterogeneous in their behavior, they tend to be more aggressive when arising in the pancreas. Pancreatic NET (panNET) represents three percent of all primary pancreatic neoplasms. Symptomatic and progressive panNETs are generally treated with cytotoxic chemotherapy, whereas molecular t...
متن کاملA Rare Gastric Carcinoma - Neuroendocrine Tumors
Neuroendocrine tumors, or more properly gastro-entero-pancreatic tumors (GEP-NETs), are cancers of the interface between the endocrine (hormonal) system and the nervous system. A neuroendocrine tumor begins in the hormone-producing cells of the body’s neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cell...
متن کاملMGUS: not so benign after all.
I t is well appreciated that persons with multiple myeloma have an increased risk of venous thrombosis. More recently, this relative risk has been shown to be increased further in these patients while on therapy with thalidomide and its derivatives. The mechanism of this increased risk for thrombosis has traditionally been attributed to traditional neoplasia risks for thrombosis, such as decrea...
متن کاملLean NAFLD: A not so benign condition?
Nonalcoholic fatty liver disease (NAFLD) is a worldwide epidemic with global prevalence estimated at 25%. Although NAFLD is usually associated with obesity, patients who are not obese can also present with NAFLD; this is known as “lean NAFLD.” Lean NAFLD is defined as NAFLD that develops in patients with a body mass index (BMI) <25 kg/m. The prevalence of lean NAFLD varies from 7% in the United...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista Española de Enfermedades Digestivas
سال: 2016
ISSN: 1130-0108
DOI: 10.17235/reed.2016.4672/2016